Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
11,172,927
-
Share change
-
+1,428,769
-
Total reported value
-
$143,012,000
-
Price per share
-
$12.80
-
Number of holders
-
21
-
Value change
-
+$18,288,250
-
Number of buys
-
10
-
Number of sells
-
2
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q4 2017
As of 31 Dec 2017,
AC Immune SA - SHS (ACIU) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,172,927 shares.
The largest 10 holders included
FMR LLC, Duquesne Family Office LLC, Temasek Holdings (Private) Ltd, PointState Capital LP, Artal Group S.A., Tekla Capital Management LLC, CITADEL ADVISORS LLC, MORGAN STANLEY, Belpointe Asset Management LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.